RECRUITING

Gii'Igoshimong: Sitting With Your First Family

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

The goal of this randomized wait-list control study is to understand the relationship between ceremony and substance use (SU), SU risk (e.g., SU severity, depressive symptoms) and protective factors (e.g., spirituality, community support). The main questions it aims to answer are: * Will adults enrolled in Gii'igoshimong show improved SU outcomes compared to those in control groups? * Will self-relevant processing networks activated during stimulus engagement increase from pre- to post- engagement in ceremony and at 6-month follow-up? Researchers will compare adults that complete Gii'igoshimong with those that do not complete Gii'igoshimong to see if health outcomes are different. After completing baseline assessments, participants will be randomized to complete Gii'igoshimong now (intervention) or after the participants have completed the 1 month and 6-month post assessments (waitlist control). All participants (intervention and waitlist control) within a cohort will complete 1 month and 6 month post assessments at the same time.

Official Title

The Protective Role of Ceremony Against Substance Use for American Indian Adults

Quick Facts

Study Start:2025-09-09
Study Completion:2029-05
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT07075081

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:Yes
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * Are 18 years of age or older
  2. * Self-identify as Ojibwe/Anishinaabe/Chippewa
  3. * Self-report using any kind of substances in the past 30 days
  4. * Have no history of head injury with loss of consciousness
  5. * Do not currently have Type 2 Diabetes
  6. * Are not currently pregnant
  1. * 18 years of age or younger
  2. * Does not Self-identify as Ojibwe/Anishinaabe/Chippewa
  3. * Does not self-report using any kind of substances in the past 30 days
  4. * Has history of head injury with loss of consciousness
  5. * Has Type 2 Diabetes
  6. * Currently pregnant

Contacts and Locations

Study Contact

Miigis B Gonzalez, PhD
CONTACT
2183494603
mgonza75@jhu.edu

Principal Investigator

Migis Gonzalez, PhD
PRINCIPAL_INVESTIGATOR
Johns Hopkins University

Study Locations (Sites)

Great Lakes Hub
Duluth, Minnesota, 55812
United States

Collaborators and Investigators

Sponsor: Johns Hopkins Bloomberg School of Public Health

  • Migis Gonzalez, PhD, PRINCIPAL_INVESTIGATOR, Johns Hopkins University

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2025-09-09
Study Completion Date2029-05

Study Record Updates

Study Start Date2025-09-09
Study Completion Date2029-05

Terms related to this study

Additional Relevant MeSH Terms

  • Substance Use
  • Mental Health Issue